Disclosure Statement: Clinical Care for Autistic Adults
All individuals in a position to control the content of this activity have been asked to disclose any relationship they have with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The following planners, speakers, and content reviewers have reported relevant financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed for these individuals have been mitigated:
NAME | COMPANY | RELATIONSHIP |
---|---|---|
Course Planners: | ||
Christopher McDougle, MD | Precidiag | Consultant |
Sage Therapeutics | Consultant | |
Acadia Pharmaceuticals | Consultant | |
Receptor Life Sciences | Consultant | |
Course Faculty: | ||
Sarah Spence, MD, PhD | GW Pharmaceuticals | Investigator |
All other individuals including course directors, planners, reviewers, faculty, staff, etc., who are in a position to control the content of this educational activity have reported no relevant financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.